Publications

 

  • Marson DC. Clinical and ethical aspects of financial capacity in dementia: a commentary. Am J Geriatr Psychiatry. 2013 Apr;21(4):382-90. doi:10.1016/j.jagp.2013.01.033. Epub 2013 Feb 6. PubMed PMID: 23498385.
  • Stoeckel LE, Stewart CC, Griffith HR, Triebel K, Okonkwo OC, den Hollander JA,Martin RC, Belue K, Copeland JN, Harrell LE, Brockington JC, Clark DG, Marson DC. MRI volume of the medial frontal cortex predicts financial capacity in patients with mild Alzheimer's disease. Brain Imaging Behav. 2013 Mar 17. [Epub ahead of print] PubMed PMID: 23504597
  • Cummings JL, Geldmacher D, Farlow M, Sabbagh M, Christensen D, Betz P. High-Dose Donepezil (23 mg/day) for the Treatment of Moderate and Severe Alzheimer's Disease: Drug Profile and Clinical Guidelines. CNS Neurosci Ther. 2013 Mar 6. doi: 10.1111/cns.12076. [Epub ahead of print] PubMed PMID: 23462265.
  •  Holton P, Ryten M, Nalls M, Trabzuni D, Weale ME, Hernandez D, Crehan H, Gibbs JR, Mayeux R, Haines JL, Farrer LA, Pericak-Vance MA, Schellenberg GD; Alzheimer's Disease Genetics Consortium, Ramirez-Restrepo M, Engel A, Myers AJ, Corneveaux JJ, Huentelman MJ, Dillman A, Cookson MR, Reiman EM, Singleton A, Hardy J, Guerreiro R, Apostolova LG, Arnold SE, Baldwin CT, Barber R, Barmada MM, Beach TG, Beecham GW, Beekly D, Bennett DA, Bigio EH, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Burke JR, Buros J, Buxbaum JD, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carrasquillo MM, Carroll SL, Chui HC, Clark DG, Cotman CW, Crane PK, Crocco EA, Cruchaga C, Cummings JL, De Jager PL, DeCarli C, DeKosky ST, Demirci FY, Diaz-Arrastia R, Dick M, Dickson DW, Duara R, Ellis WG, Ertekin-Taner N, Evans D, Faber KM, Fallon KB, Farlow MR, Ferris S, Foroud TM, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Goate AM, Graff-Radford NR, Green RC, Growdon JH, Hakonarson H, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jarvik GP, Jicha GA, Jin LW, Jun G, Kamboh MI, Karlawish J, Karydas A, Kauwe JS, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer P, Kukull WA, Lah JJ, Larson EB, Levey AI, Lieberman AP, Lopez OL, Lunetta KL, Mack WJ, Marson DC, Martin ER, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Montine TJ, Morris JC, Naj AC, Nowotny P, Parisi JE, Peskind E, Petersen RC, Poon WW, Potter H, Quinn JF, Raj A, Rajbhandary RA, Raskind M, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rogaeva E, Rosenberg RN, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Shelanski ML, Smith CD, Sonnen JA, Spina S, St George-Hyslop P, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Tsuang DW, Valladares O, Van Deerlin VM, Vardarajan BN, Vinters HV, Vonsattel JP, Wang LS, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Wright CB, Younkin SG. Initial assessment of the pathogenic mechanisms of the  recently identified Alzheimer risk Loci. Ann Hum Genet. 2013 Mar;77(2):85-105. doi: 10.1111/ahg.12000. Epub 2013 Jan 30. PubMed PMID: 23360175; PubMed Central  PMCID: PMC3578142.
  • Seward ME, Swanson E, Norambuena A, Reimann A, Cochran JN, Li R, Roberson ED, Bloom GS. Amyloid-β Signals Through Tau to Drive Ectopic Neuronal Cell Cycle Re-entry in Alzheimer's Disease. J Cell Sci. 2013 Jan 23. [Epub ahead of print] PubMed PMID: 23345405.
  • Martin RC, Triebel K, Dreer LE, Novack TA, Turner C, Marson DC. Neurocognitive predictors of financial capacity in traumatic brain injury. J Head Trauma Rehabil. 2012 Nov-Dec;27(6):E81-90. doi: 10.1097/HTR.0b013e318273de49. PubMed PMID: 23131973.
  • Geldmacher DS, Levin BE, Wright CB. Characterizing healthy samples for studies of human cognitive aging. Front Aging Neurosci. 2012;4:23. doi:10.3389/fnagi.2012.00023. Epub 2012 Sep 12. PubMed PMID: 22988440; PubMed Central  PMCID: PMC3439639.
  • Alexander GE, Ryan L, Bowers D, Foster TC, Bizon JL, Geldmacher DS, Glisky EL. Characterizing cognitive aging in humans with links to animal models. Front Aging Neurosci. 2012;4:21. doi: 10.3389/fnagi.2012.00021. Epub 2012 Sep 12. PubMed PMID: 22988439; PubMed Central PMCID: PMC3439638.
  • Roberson ED, Defazio RA, Barnes CA, Alexander GE, Bizon JL, Bowers D, Foster TC, Glisky EL, Levin BE, Ryan L, Wright CB, Geldmacher DS. Challenges and opportunities for characterizing cognitive aging across species. Front Aging Neurosci. 2012;4:6. doi: 10.3389/fnagi.2012.00006. Epub 2012 Sep 12. PubMed PMID: 22988434; PubMed Central PMCID: PMC3439634.
  • Salloway S, Mintzer J, Cummings JL, Geldmacher D, Sun Y, Yardley J, Mackell J. Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2012 Sep;27(6):421-32. doi: 10.1177/1533317512454708. PubMed PMID:  22930699.
  • Dodge HH, Marson DC. Illuminating cognitive dedifferentiation at the end of life. Neurology. 2012 Apr 10;78(15):1110-1. doi: 10.1212/WNL.0b013e31824f80b9. Epub 2012 Apr 4. PubMed PMID: 22491863.
  • Doody RS, Geldmacher DS, Farlow MR, Sun Y, Moline M, Mackell J. Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine. Dement Geriatr Cogn Disord. 2012;33(2-3):164-73. doi: 10.1159/000338236. Epub 2012 May 10. PubMed PMID: 22572767.